The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Healthcare Realty Trust Inc

NYSE: HR
Last

(U.S.) $33.56

Today's change-0.18 -0.53%
Updated May 25 4:02 PM EDT. Delayed by at least 15 minutes.
 

Healthcare Realty Trust Inc

NYSE: HR
Last

(U.S.) $33.56

Today's change-0.18 -0.53%
Updated May 25 4:02 PM EDT. Delayed by at least 15 minutes.

Healthcare Realty Trust Inc down (U.S.)$0.18

Healthcare Realty Trust Inc closed lower Thursday, dropping (U.S.)$0.18 or 0.53% to (U.S.)$33.56. Over the last five days, shares have gained 2.04% and 10.69% year to date. Shares have underperformed the S&P 500 by 7.89% during the last year.

Key company metrics

  • Open(U.S.) $33.82
  • Previous close(U.S.) $33.74
  • High(U.S.) $33.87
  • Low(U.S.) $33.51
  • Bid / Ask-- / --
  • YTD % change+10.69%
  • Volume480,460
  • Average volume (10-day)986,364
  • Average volume (1-month)784,316
  • Average volume (3-month)646,040
  • 52-week range(U.S.) $26.66 to (U.S.) $36.60
  • Beta0.34
  • Trailing P/E35.31×
  • P/E 1 year forward52.72×
  • Forward PEG13.18×
  • Indicated annual dividend(U.S.) $1.20
  • Dividend yield3.58%
  • Trailing EPS(U.S.) $0.95
Updated May 25 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+26.06%

Based on its net profit margin of 26.06%, Healthcare Realty Trust Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.06%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue105105104103
Total other revenue--------
Total revenue105105104103
Gross profit67686666
Total cost of revenue38373836
Total operating expense82807876
Selling / general / administrative9998
Research & development--------
Depreciation / amortization34343231
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income23252527
Interest income (expense), net non-operating-14-14-14-15
Gain (loss) on sale of assets234100
Other--------
Income before tax32531212
Income after tax32531212
Income tax, total--------
Net income32521212
Total adjustments to net income--------
Net income before extra. items32531212
Minority interest--0----
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items32531212
Inc. avail. to common incl. extra. items32521212
Diluted net income32521212
Dilution adjustment--------
Diluted weighted average shares116115115105
Diluted EPS excluding extraordinary itemsvalue per share0.280.460.100.12
Dividends per sharevalue per share0.300.300.300.30
Diluted normalized EPSvalue per share0.080.380.100.12